Bronte Capital Management Pty Ltd Q2 2026 Portfolio Activity: Major Buys and Sells Observed
This article summarizes observable stock purchases and sales by Bronte Capital Management Pty Ltd in the second quarter of 2026, based on available data.
Bronte Capital Management Pty Ltd's portfolio saw significant changes during Q2 2026. The investor observed notable buying activity in several stocks while exiting or reducing positions in others.
Significant Purchases: Bronte Capital increased its stake in Disney (DIS), one of the largest buys during this period, with a +94.02% change in shares and allocation increasing to 3.9%. Similarly, there was substantial buying activity noted for Brown-Forman (BF-B), evidenced by a +100.0% increase in holdings.
Other purchases included the initiation of positions in previously unheld stocks, such as ISHares TR ETF and TYL stock, although specific share changes for these last two are indicated only in the portfolio indicators.
Significant Sales: The investor was notably active in selling or reducing positions. Holdings of Herbalife Nutrition (G4412G101), a company previously held, decreased significantly by -65.59%.
Reductions were also observed in major holdings like Alphabet Inc (GOOGL) (-20.01%), Regeneron Pharmaceuticals (REGN) (-5.89%), and others, including some Interactive Brokers Group (IBKR) shares.
Sector Analysis: The portfolio's sector allocations remained relatively stable compared to the previous period, with Financial Services still being a major component at 29.03% allocation value. Changes were noted across various sectors, including Communication Services and Healthcare due to adjustments in holdings like GOOGL/DIS and REGN.
Overall, Bronte Capital Management Pty Ltd's Q2 activity involved strategic shifts, focusing on growth areas while exiting or reducing exposure in certain sectors or specific stocks. For more detailed information, please visit Bronte Capital Management Pty Ltd and explore their holdings.